Document is current
Any future updates will be listed below
-
Authors
Zhong, Yanghao
Sahan, Ayse Z. https://orcid.org/0000-0003-4661-035X
Shao, Zhengyao https://orcid.org/0000-0003-2965-8335
Zhang, Qian-yi
Zhou, Xin https://orcid.org/0009-0008-2426-2247
Haggett, Jack G.
Koshizuka, Keiichi
Myers, Samuel A.
Gutkind, J. Silvio
Zhang, Jin https://orcid.org/0000-0001-7145-7823
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (CA197622)
U.S. Department of Health & Human Services | National Institutes of Health (DE030497)
U.S. Department of Health & Human Services | National Institutes of Health (DE032886)
U.S. Department of Health & Human Services | National Institutes of Health (GM007752)
- License Information
-
More Information
Article History
Received: 8 August 2024
Accepted: 5 March 2026
First Online: 14 May 2026
Competing interests
: A provisional patent application has been submitted by the University of California, San Diego for the genetically encodable and subcellularly targeted mTORC1 inhibitors presented in this paper, with J.Z., Y.Z. and A.Z.S. as inventors.
